EXHIBIT 107
CALCULATION OF FILING FEE TABLE
Form S-8
(Form Type)
Accelerate Diagnostics, Inc.
(Exact Name of Registrant as Specified in its Charter)
| Table 1—Newly Registered Securities | |||||||
| Security Type |
Security Class Title |
Fee Calculation Rule |
Amount Registered | Proposed Maximum Offering Price Per Unit |
Maximum Aggregate Offering Price |
Fee Rate | Amount of Registration Fee |
| Equity | Common Stock, $0.001 par value per share | Other(1) | 4,000,000 (2)(3) | $0.89(1) | $3,560,000 | 0.00014760 | $525.46 |
| Total Offering Amounts | $3,560,000 | $525.46 | |||||
| Total Fee Offsets | $0 | ||||||
| Net Fee Due | $525.46 | ||||||
| (1) | Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(h) and Rule 457(c) promulgated under the Securities Act of 1933, as amended (the “Securities Act”), based upon the average of the high and low prices of the registrant’s common stock, $0.001 par value per share (“Common Stock”), as reported on The Nasdaq Capital Market on May 9, 2024. |
| (2) | Pursuant to Rule 416(a) promulgated under the Securities Act, this registration statement shall also cover any additional shares of Common Stock that become issuable under the Accelerate Diagnostics, Inc. 2022 Omnibus Equity Incentive Plan (as amended, the “Plan”) by reason of any stock splits, stock dividends or similar transactions. |
| (3) | Represents an additional 4,000,000 shares of Common Stock issuable under the Plan. The registrant previously filed Registration Statements on Form S-8 (Nos. 333-265126 and 333-272792) with respect to shares issuable under the Plan. |